Vita Coco's Q3 Surge Prompts Upgrade, Valuation Now Reasonable

What happened

Vita Coco reported Q3 2026 revenues of $244M, up 34% YoY, with organic sales up 18% and private label surging 152%, leading management to raise FY26 guidance to net sales of $810-820M and adjusted EBITDA of $170-175M. The company's gross margin is now expected around 40%, a significant improvement from the mid-30s compression seen in 2025 due to tariffs. With a debt-free balance sheet and accelerating growth, Seeking Alpha upgraded the stock to Buy, arguing the valuation now aligns with prospects. However, the prior 'Potential Sell' thesis was based on a rich multiple and structural risks; the new data suggests those risks may have been overstated or resolved, but competition and execution remain key watch items. The shift in fundamentals warrants a re-evaluation of the investment stance.

Implication

The Q3 2026 results indicate that Vita Coco's growth has re-accelerated, driven by branded coconut water and a surprising surge in private label, which may reflect new contracts or market share gains. The raised guidance and margin recovery to ~40% suggest that tariff headwinds have been mitigated, either through pricing, sourcing changes, or policy relief. With a net cash position and strong free cash flow, the company has financial flexibility to invest in innovation and buybacks. However, the stock is still likely to trade at a premium to the sector, so any slowdown in growth or margin pressure could lead to multiple compression. Investors should monitor quarterly trends in branded volume, private label trajectory, and gross margin to confirm the sustainability of the improvement.

Thesis delta

The previous 'Potential Sell' thesis was predicated on overvaluation and margin compression from tariffs. The new Q3 2026 results show accelerating growth, margin recovery, and raised guidance, which, combined with a more reasonable valuation as argued by the article, shifts the risk/reward to neutral or positive. While risks remain, the bear case has weakened; the thesis now leans more constructive, but vigilance is needed on competitive dynamics and execution of innovation.